86 related articles for article (PubMed ID: 27822759)
1. Cytokine pattern of the breast tumor supernatant.
Autenshlyus AI; Kunts TA; Karpukhina KV; Mikhaylova ES; Varaksin NA; Marinkin IO; Lyakhovich VV
Dokl Biol Sci; 2016 Sep; 470(1):247-248. PubMed ID: 27822759
[TBL] [Abstract][Full Text] [Related]
2. Cytokine profiles of tumor supernatants in invasive ductal cancer and fibroadenoma of the breast and its relationship with VEGF-A expression in the tumors.
Autenshlyus AI; Arkhipov SA; Kunts TA; Marinkin IO; Mikhailova ES; Karpukhina XV; Varaksin NA
Int J Immunopathol Pharmacol; 2017 Mar; 30(1):83-88. PubMed ID: 27903846
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases].
Autenshlyus AI; Studenikina AA; Bernado AV; Mikhailova ES; Proskura AV; Sidorov SV; Varaksin NA; Lyakhovich VV
Biomed Khim; 2019 Aug; 65(5):418-423. PubMed ID: 31666415
[TBL] [Abstract][Full Text] [Related]
4. CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.
Lü X; Xu K; Lü H; Yin Y; Ma C; Liu Y; Li H; Suo Z
Ultrastruct Pathol; 2011 Apr; 35(2):72-8. PubMed ID: 21299347
[TBL] [Abstract][Full Text] [Related]
5. B7-H4 expression in human infiltrating ductal carcinoma‑associated macrophages.
Liu L; Li D; Chen S; Zhao R; Pang D; Li D; Fu Z
Mol Med Rep; 2016 Sep; 14(3):2135-42. PubMed ID: 27430170
[TBL] [Abstract][Full Text] [Related]
6. [Cytokine production by blood immune cells, tumor and its microenvironment, characteristic of extracellular matrix in patients with invasive ductal carcinoma of no special type].
Autenshlyus AI; Davletova KI; Studenikina AA; Mikhaylova ES; Varaksin NA; Zhurakovsky IP; Proskura AV; Sidorov SV; Lyakhovich VV
Biomed Khim; 2019 Aug; 65(5):424-431. PubMed ID: 31666416
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-19 in breast cancer.
Chen YY; Li CF; Yeh CH; Chang MS; Hsing CH
Clin Dev Immunol; 2013; 2013():294320. PubMed ID: 23710200
[TBL] [Abstract][Full Text] [Related]
8. The role of micronucleus scoring in fine needle aspirates of ductal carcinoma of the breast.
Samanta S; Dey P; Nijhawan R
Cytopathology; 2011 Apr; 22(2):111-4. PubMed ID: 20553316
[TBL] [Abstract][Full Text] [Related]
9. Comparison of telomere length and telomerase activation between breast fibroadenoma and infiltrating ductal carcinoma in Malaysian women.
Looi LM; Cheah PL; Ng MH; Yip CH; Mun KS; Rahman NA
Asian Pac J Cancer Prev; 2010; 11(3):713-6. PubMed ID: 21039041
[TBL] [Abstract][Full Text] [Related]
10. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
El Sharkawy SL; Farrag AR
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment.
Sanguinetti A; Santini D; Bonafè M; Taffurelli M; Avenia N
World J Surg Oncol; 2015 Mar; 13():129. PubMed ID: 25881039
[TBL] [Abstract][Full Text] [Related]
12. Different transendothelial migration behaviour pattern of blood monocytes derived from patients with benign and malignant diseases of the breast.
Gebhard B; Gnant M; Schütz G; Roka S; Weigel G; Kandioler D; Taucher S; Grünberger T; Roth E; Jakesz R; Spittler A
Anticancer Res; 2000; 20(6B):4599-604. PubMed ID: 11205309
[TBL] [Abstract][Full Text] [Related]
13. Differential inflammatory activation of IL-6 (-/-) astrocytes.
Bolin LM; Zhaung A; Strychkarska-Orczyk I; Nelson E; Huang I; Malit M; Nguyen Q
Cytokine; 2005 Apr; 30(2):47-55. PubMed ID: 15804595
[TBL] [Abstract][Full Text] [Related]
14. An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.
Hawkins O; Verma B; Lightfoot S; Jain R; Rawat A; McNair S; Caseltine S; Mojsilovic A; Gupta P; Neethling F; Almanza O; Dooley W; Hildebrand W; Weidanz J
J Immunol; 2011 Jun; 186(11):6607-16. PubMed ID: 21515791
[TBL] [Abstract][Full Text] [Related]
15. Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction.
Morikawa A; Takeuchi T; Kito Y; Saigo C; Sakuratani T; Futamura M; Yoshida K
PLoS One; 2015; 10(5):e0125762. PubMed ID: 25955408
[TBL] [Abstract][Full Text] [Related]
16. Expression of the serine protease, matriptase, in breast ductal carcinoma of Chinese women: correlation with clinicopathological parameters.
Jin JS; Cheng TF; Tsai WC; Sheu LF; Chiang H; Yu CP
Histol Histopathol; 2007 Mar; 22(3):305-9. PubMed ID: 17163404
[TBL] [Abstract][Full Text] [Related]
17. Cytokine production by the tumor from patients with breast cancer in different age groups.
Kunts TA; Mikhaylova ES; Marinkin IO; Varaksin NA; Autenshlyus AI; Lyakhovich VV
Dokl Biol Sci; 2017 Jul; 475(1):172-174. PubMed ID: 28861874
[TBL] [Abstract][Full Text] [Related]
18. A New Method for Obtaining Tumor Interstitial Fluid Applied to Cytokine Analysis of Breast Carcinoma Samples.
Dantas FT; Felix-Silva PH; Angotti-Carrara HH; Dos-Reis FJC; Junior MT; DE-Souza SLS; Palioto DB
Anticancer Res; 2022 Mar; 42(3):1327-1332. PubMed ID: 35220223
[TBL] [Abstract][Full Text] [Related]
19. Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast.
Kuerer HM; Peoples GE; Sahin AA; Murray JL; Singletary SE; Castilleja A; Hunt KK; Gershenson DM; Ioannides CG
J Interferon Cytokine Res; 2002 May; 22(5):583-92. PubMed ID: 12060497
[TBL] [Abstract][Full Text] [Related]
20. Image analysis of irregularity of cluster shape in cytological diagnosis of breast tumors: cluster analysis with 2D-fractal dimension.
Yokoyama T; Kawahara A; Kage M; Kojiro M; Takayasu H; Sato T
Diagn Cytopathol; 2005 Aug; 33(2):71-7. PubMed ID: 16007648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
